C1QDC2 inhibitors belong to a specialized class of chemical compounds that have gained attention in the field of molecular biology and protein function research. C1QDC2, also known as Complement C1q Domain-Containing Protein 2, is a protein with emerging significance in various cellular processes, although its exact functions and mechanisms are still under investigation. The term C1QDC2 inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of C1QDC2. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with C1QDC2.
C1QDC2 inhibitors typically function by interfering with the interactions of C1QDC2 with other cellular proteins or biomolecules, thereby affecting its role in cellular processes. This interference can lead to alterations in various aspects of cell biology, potentially impacting cellular signaling, protein-protein interactions, or other molecular events. Researchers employ C1QDC2 inhibitors to gain insights into the physiological roles and molecular interactions of C1QDC2 within cells, aiming to advance our understanding of the fundamental mechanisms involved in cellular processes where C1QDC2 may play a role. Through the study of C1QDC2 inhibitors, scientists seek to unravel the complexities of protein function, cellular pathways, and the broader field of molecular biology, contributing to our knowledge of how cells orchestrate various processes to maintain their functionality and adapt to changing conditions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and disrupts normal cell division, potentially affecting the expression of various proteins. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine inhibits microtubule formation, leading to disrupted mitosis and potentially impacting protein synthesis and cellular processes. | ||||||
Topotecan | 123948-87-8 | sc-338718 | 100 mg | $582.00 | ||
Topotecan inhibits topoisomerase I, leading to DNA damage and potentially affecting gene transcription and protein synthesis. | ||||||
(+)-Irinotecan | 97682-44-5 | sc-269253 | 10 mg | $62.00 | 1 | |
Irinotecan is a topoisomerase I inhibitor that causes DNA strand breaks, potentially impacting gene expression and protein production. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Leflunomide inhibits dihydroorotate dehydrogenase, affecting pyrimidine synthesis, which can influence RNA and protein synthesis. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $37.00 $109.00 | 1 | |
This compound inhibits inosine monophosphate dehydrogenase, crucial for purine synthesis, affecting RNA and protein synthesis. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine can affect lysosomal function and autophagy, potentially influencing various cellular pathways, including protein expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that affects protein degradation, potentially influencing levels of various proteins. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Carfilzomib, another proteasome inhibitor, can impact protein turnover and affect various cellular pathways, including protein synthesis. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis and induces ER stress, which can affect protein folding and expression. | ||||||